Back
A Phase II Study of Antineoplastons A10 and AS2-1 in Children with Low-Grade Astrocytomas—Final Report (Protocol BT-13)
Stanislaw R. Burzynski, Tomasz J. Janicki, Gregory S. Burzynski
J. Cancer Ther. Vol.7 No.12, November 04, 2016  DOI: 10.4236/jct.2016.712083
       (PDF  1314K)     HTML      XML
A Phase II Study of Antineoplastons A10 and AS2-1 in Adult Patients with Primary Brain Tumors—Final Report (Protocol BT-09)
Stanislaw R. Burzynski, Tomasz J. Janicki, Gregory S. Burzynski
J. Cancer Ther. Vol.6 No.12, November 25, 2015  DOI: 10.4236/jct.2015.612116
       (PDF  464K)     HTML      XML
Recurrent Glioblastoma Multiforme—A Strategy for Long-Term Survival
Stanislaw R. Burzynski, Gregory S. Burzynski, Tomasz J. Janicki
J. Cancer Ther. Vol.5 No.10, September 10, 2014  DOI: 10.4236/jct.2014.510101
       (PDF  3800K)     HTML     
A Phase II Study of Antineoplastons A10 and AS2-1 in Adult Patients with Recurrent Glioblastoma Multiforme: Final Report (Protocol BT-21)
Stanislaw R. Burzynski, Tomasz J. Janicki, Gregory S. Burzynski
J. Cancer Ther. Vol.5 No.10, September 10, 2014  DOI: 10.4236/jct.2014.510100
       (PDF  2876K)     HTML     
A Phase II Study of Antineoplastons A10 and AS2-1 in Children with Brain Tumors. Final Report (Protocol BT-10)
Stanislaw R. Burzynski, Tomasz J. Janicki, Gregory S. Burzynski, Ania Marszalek
J. Cancer Ther. Vol.8 No.2, February 16, 2017  DOI: 10.4236/jct.2017.82015
       (PDF  452K)     HTML      XML
 
 
Top